InvestorsHub Logo
Followers 99
Posts 5356
Boards Moderated 0
Alias Born 08/27/2011

Re: Pyrrhonian post# 63742

Sunday, 06/05/2016 5:38:03 PM

Sunday, June 05, 2016 5:38:03 PM

Post# of 703213
What I think is the trial will add MOS to PFS as a primary endpoint. MOS is what matters here the FDA knows it Biden knows it.

We certainly do not need to raise the enrollment numbers the MOS will beat Temodar by a year minimum.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News